Compagnie Lombard Odier SCmA’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,000
Closed -$65.6K 444
2024
Q3
$65.6K Sell
5,000
-2,500
-33% -$32.8K ﹤0.01% 320
2024
Q2
$105K Sell
7,500
-4,500
-38% -$63.3K ﹤0.01% 281
2024
Q1
$203K Hold
12,000
﹤0.01% 255
2023
Q4
$169K Hold
12,000
﹤0.01% 303
2023
Q3
$124K Hold
12,000
﹤0.01% 332
2023
Q2
$198K Hold
12,000
0.01% 266
2023
Q1
$110K Sell
12,000
-40,000
-77% -$366K ﹤0.01% 365
2022
Q4
$372K Buy
52,000
+33,000
+174% +$236K 0.01% 222
2022
Q3
$95K Hold
19,000
﹤0.01% 391
2022
Q2
$47K Hold
19,000
﹤0.01% 439
2022
Q1
$130K Buy
19,000
+13,000
+217% +$88.9K ﹤0.01% 350
2021
Q4
$48K Hold
6,000
﹤0.01% 510
2021
Q3
$59K Hold
6,000
﹤0.01% 485
2021
Q2
$40K Hold
6,000
﹤0.01% 507
2021
Q1
$54K Hold
6,000
﹤0.01% 494
2020
Q4
$40K Hold
6,000
﹤0.01% 458
2020
Q3
$30K Hold
6,000
﹤0.01% 419
2020
Q2
$48K Sell
6,000
-13,000
-68% -$104K ﹤0.01% 369
2020
Q1
$151K Hold
19,000
0.01% 260
2019
Q4
$143K Hold
19,000
0.01% 276
2019
Q3
$79K Hold
19,000
﹤0.01% 323
2019
Q2
$55K Hold
19,000
﹤0.01% 349
2019
Q1
$28K Hold
19,000
﹤0.01% 438
2018
Q4
$49K Hold
19,000
﹤0.01% 384
2018
Q3
$83K Hold
19,000
﹤0.01% 369
2018
Q2
$117K Hold
19,000
﹤0.01% 335
2018
Q1
$139K Sell
19,000
-19,000
-50% -$139K 0.01% 341
2017
Q4
$312K Buy
38,000
+19,000
+100% +$156K 0.01% 341
2017
Q3
$199K Buy
+19,000
New +$199K 0.01% 363
2017
Q1
Sell
-3,000
Closed -$31K 715
2016
Q4
$31K Hold
3,000
﹤0.01% 661
2016
Q3
$37K Hold
3,000
﹤0.01% 718
2016
Q2
$32K Hold
3,000
﹤0.01% 724
2016
Q1
$33K Hold
3,000
﹤0.01% 765
2015
Q4
$37K Hold
3,000
﹤0.01% 727
2015
Q3
$49K Hold
3,000
﹤0.01% 608
2015
Q2
$64K Hold
3,000
﹤0.01% 615
2015
Q1
$54K Buy
+3,000
New +$54K ﹤0.01% 774